In spite of Outset Medical Inc.’s (NASDAQ:OM) recent upswing, most analysts remain bearish.

The closing price of Outset Medical Inc. (NASDAQ: OM) was $20.20 for the day, down -8.56% from the previous closing price of $22.09. In other words, the price has decreased by -$1.89 from its previous closing price. On the day, 536782 shares were traded. OM stock price reached its highest trading level at $22.35 during the session, while it also had its lowest trading level at $19.82.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



Our analysis of OM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.50 and its Current Ratio is at 7.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.45.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 17 when Brottem John L. sold 2,732 shares for $20.08 per share. The transaction valued at 54,859 led to the insider holds 58,945 shares of the business.

Trigg Leslie sold 2,962 shares of OM for $58,973 on May 16. The Chair and CEO now owns 409,489 shares after completing the transaction at $19.91 per share. On May 16, another insider, Ahmed Nabeel, who serves as the Chief Financial Officer of the company, sold 1,532 shares for $19.91 each. As a result, the insider received 30,502 and left with 93,706 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 1.03B and an Enterprise Value of 884.92M. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.33 while its Price-to-Book (P/B) ratio in mrq is 4.56. Its current Enterprise Value per Revenue stands at 7.48 whereas that against EBITDA is -5.41.

Stock Price History:

Over the past 52 weeks, OM has reached a high of $30.55, while it has fallen to a 52-week low of $11.41. The 50-Day Moving Average of the stock is 19.30, while the 200-Day Moving Average is calculated to be 20.52.

Shares Statistics:

OM traded an average of 535.06K shares per day over the past three months and 434.27k shares per day over the past ten days. A total of 48.78M shares are outstanding, with a floating share count of 47.91M. Insiders hold about 1.10% of the company’s shares, while institutions hold 106.74% stake in the company. Shares short for OM as of Apr 27, 2023 were 6.82M with a Short Ratio of 6.82M, compared to 6.07M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 13.85% and a Short% of Float of 16.37%.

Earnings Estimates

The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.78 for the current quarter, with a high estimate of -$0.71 and a low estimate of -$0.9, while EPS last year was -$0.92. The consensus estimate for the next quarter is -$0.78, with high estimates of -$0.69 and low estimates of -$0.9.

Analysts are recommending an EPS of between -$2.79 and -$3.62 for the fiscal current year, implying an average EPS of -$3.1. EPS for the following year is -$2.95, with 4 analysts recommending between -$2.53 and -$3.72.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 5 analysts. It ranges from a high estimate of $35.37M to a low estimate of $34.1M. As of the current estimate, Outset Medical Inc.’s year-ago sales were $25.06M, an estimated increase of 38.80% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $37.57M, an increase of 35.30% less than the figure of $38.80% in the same quarter last year. There is a high estimate of $38.12M for the next quarter, whereas the lowest estimate is $37.1M.

A total of 6 analysts have provided revenue estimates for OM’s current fiscal year. The highest revenue estimate was $148.04M, while the lowest revenue estimate was $146.9M, resulting in an average revenue estimate of $147.34M. In the same quarter a year ago, actual revenue was $115.38M, up 27.70% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $198.72M in the next fiscal year. The high estimate is $209.94M and the low estimate is $190.29M. The average revenue growth estimate for next year is up 34.90% from the average revenue estimate for this year.